Royal Bank of Canada’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.2M | Buy |
121,152
+38,342
| +46% | +$4.82M | ﹤0.01% | 1565 |
|
|
2025
Q1 | $9.16M | Buy |
82,810
+22,224
| +37% | +$2.46M | ﹤0.01% | 1617 |
|
|
2024
Q4 | $8.27M | Sell |
60,586
-192,324
| -76% | -$26.2M | ﹤0.01% | 1689 |
|
|
2024
Q3 | $29.1M | Buy |
252,910
+87,481
| +53% | +$10.1M | 0.01% | 993 |
|
|
2024
Q2 | $22.8M | Buy |
165,429
+26,455
| +19% | +$3.64M | 0.01% | 1065 |
|
|
2024
Q1 | $19.2M | Buy |
138,974
+16,427
| +13% | +$2.27M | ﹤0.01% | 1154 |
|
|
2023
Q4 | $16.1M | Buy |
122,547
+74,419
| +155% | +$9.8M | ﹤0.01% | 1216 |
|
|
2023
Q3 | $5.41M | Buy |
48,128
+4,233
| +10% | +$476K | ﹤0.01% | 1750 |
|
|
2023
Q2 | $4.14M | Sell |
43,895
-73,828
| -63% | -$6.96M | ﹤0.01% | 1965 |
|
|
2023
Q1 | $11.9M | Sell |
117,723
-3,629
| -3% | -$367K | ﹤0.01% | 1281 |
|
|
2022
Q4 | $14.5M | Buy |
121,352
+7,454
| +7% | +$890K | ﹤0.01% | 1193 |
|
|
2022
Q3 | $12.1M | Buy |
113,898
+5,973
| +6% | +$634K | ﹤0.01% | 1223 |
|
|
2022
Q2 | $10.5M | Buy |
107,925
+36,590
| +51% | +$3.57M | ﹤0.01% | 1353 |
|
|
2022
Q1 | $6.69M | Buy |
71,335
+9,810
| +16% | +$920K | ﹤0.01% | 1752 |
|
|
2021
Q4 | $5.24M | Buy |
61,525
+1,777
| +3% | +$151K | ﹤0.01% | 2004 |
|
|
2021
Q3 | $5.73M | Sell |
59,748
-7,731
| -11% | -$742K | ﹤0.01% | 1918 |
|
|
2021
Q2 | $6.57M | Buy |
67,479
+5,656
| +9% | +$550K | ﹤0.01% | 1884 |
|
|
2021
Q1 | $6.01M | Buy |
61,823
+4,242
| +7% | +$413K | ﹤0.01% | 1854 |
|
|
2020
Q4 | $5.52M | Buy |
57,581
+15,791
| +38% | +$1.51M | ﹤0.01% | 1850 |
|
|
2020
Q3 | $4.02M | Buy |
41,790
+12,122
| +41% | +$1.17M | ﹤0.01% | 1864 |
|
|
2020
Q2 | $3.62M | Buy |
29,668
+2,016
| +7% | +$246K | ﹤0.01% | 1903 |
|
|
2020
Q1 | $2.39M | Sell |
27,652
-1,756
| -6% | -$152K | ﹤0.01% | 2023 |
|
|
2019
Q4 | $3.16M | Buy |
29,408
+4,148
| +16% | +$446K | ﹤0.01% | 2084 |
|
|
2019
Q3 | $2.28M | Buy |
25,260
+2,119
| +9% | +$191K | ﹤0.01% | 2224 |
|
|
2019
Q2 | $1.95M | Sell |
23,141
-913
| -4% | -$77.1K | ﹤0.01% | 2362 |
|
|
2019
Q1 | $2.12M | Buy |
24,054
+514
| +2% | +$45.3K | ﹤0.01% | 2217 |
|
|
2018
Q4 | $1.68M | Buy |
23,540
+10,462
| +80% | +$747K | ﹤0.01% | 2287 |
|
|
2018
Q3 | $1.61M | Buy |
13,078
+1,242
| +10% | +$153K | ﹤0.01% | 2514 |
|
|
2018
Q2 | $1.16M | Buy |
11,836
+486
| +4% | +$47.8K | ﹤0.01% | 2624 |
|
|
2018
Q1 | $941K | Buy |
11,350
+3,428
| +43% | +$284K | ﹤0.01% | 2677 |
|
|
2017
Q4 | $615K | Sell |
7,922
-151,808
| -95% | -$11.8M | ﹤0.01% | 3000 |
|
|
2017
Q3 | $9.79M | Sell |
159,730
-1,801
| -1% | -$110K | ﹤0.01% | 1295 |
|
|
2017
Q2 | $7.43M | Sell |
161,531
-52,947
| -25% | -$2.44M | ﹤0.01% | 1398 |
|
|
2017
Q1 | $9.29M | Buy |
214,478
+205,610
| +2,319% | +$8.9M | 0.01% | 1275 |
|
|
2016
Q4 | $344K | Sell |
8,868
-27,357
| -76% | -$1.06M | ﹤0.01% | 3386 |
|
|
2016
Q3 | $1.83M | Sell |
36,225
-440,927
| -92% | -$22.3M | ﹤0.01% | 2095 |
|
|
2016
Q2 | $21.7M | Buy |
477,152
+14,449
| +3% | +$657K | 0.01% | 768 |
|
|
2016
Q1 | $18.3M | Buy |
462,703
+54,345
| +13% | +$2.15M | 0.01% | 839 |
|
|
2015
Q4 | $23.1M | Buy |
408,358
+397,967
| +3,830% | +$22.5M | 0.02% | 745 |
|
|
2015
Q3 | $414K | Sell |
10,391
-15,609
| -60% | -$622K | ﹤0.01% | 3156 |
|
|
2015
Q2 | $1.24M | Buy |
26,000
+8,400
| +48% | +$401K | ﹤0.01% | 2319 |
|
|
2015
Q1 | $699K | Sell |
17,600
-46,195
| -72% | -$1.83M | ﹤0.01% | 2775 |
|
|
2014
Q4 | $1.43M | Buy |
63,795
+57,695
| +946% | +$1.29M | ﹤0.01% | 2169 |
|
|
2014
Q3 | $96K | Hold |
6,100
| – | – | ﹤0.01% | 4098 |
|
|
2014
Q2 | $91K | Hold |
6,100
| – | – | ﹤0.01% | 4096 |
|
|
2014
Q1 | $98K | Buy |
6,100
+5,000
| +455% | +$80.3K | ﹤0.01% | 4046 |
|
|
2013
Q4 | $10K | Sell |
1,100
-2,100
| -66% | -$19.1K | ﹤0.01% | 4820 |
|
|
2013
Q3 | $36K | Sell |
3,200
-1,500
| -32% | -$16.9K | ﹤0.01% | 4377 |
|
|
2013
Q2 | $63K | Buy |
+4,700
| New | +$63K | ﹤0.01% | 3973 |
|